Carisma Therapeutics Inc. is a biopharmaceutical company that focuses on the development of novel chimeric antigen receptor macrophage (CAR-M) immunotherapies. With their innovative approach, they aim to treat a wide range of cancers and potentially revolutionize cancer therapy.
Notification